Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Fatigue 21Neoplasms 6cyclopia sequence 4Glioma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Sleepiness 2Sleep Initiation and Maintenance Disorders 2Pain 2Lung Neoplasms 2Head and Neck Neoplasms 2Breast Neoplasms 2Unspecified Adult Solid Tumor, Protocol Specific 1Sleep Wake Disorders 1Prostatic Neoplasms 1Parasomnias 1Oligodendroglioma 1Neurotoxicity Syndromes 1Nervous System Neoplasms 1Multiple Myeloma 1Meningioma 1Melanoma 1Lymphoma, B-Cell 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Laryngeal Diseases 1Gliosarcoma 1Glioma, Subependymal 1Glioblastoma 1Esophageal Neoplasms 1

Interventions

pembrolizumab 300Nivolumab 273Ipilimumab 250aldesleukin 137Cyclophosphamide 135Interleukin-2 105trametinib 82dabrafenib 76Temozolomide 75Dacarbazine 74Vemurafenib 71fludarabine 67fludarabine phosphate 61Biopsy 49binimetinib 47sargramostim 44Radiosurgery 44Bevacizumab 43Paclitaxel 42encorafenib 40incomplete Freund's adjuvant 39atezolizumab 38Radiotherapy 37Cisplatin 36CTLA-4 Antigen 36Carboplatin 35cobimetinib 34Specimen Handling 34Magnetic Resonance Spectroscopy 34Introns 33

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Melanoma × Modafinil × Clear all
NCT03864042 2024-09-27

Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors

Pfizer

Phase 1 Completed
56 enrolled 158 charts
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡